HOLOCENE ADVISORS, LP – Aclaris Therapeutics, Inc. Transaction History
HOLOCENE ADVISORS, LP portfolio value:
$32.43M
portfolio value
HOLOCENE ADVISORS, LP quarter portfolio value change:
+12.75%
quarter
Aclaris Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 3.66M | $15.74 | 2.06M | |
| Q2 2022 | share | 0.00% | 0 shares | -6.76M | $13.96 | 2.06M | |
| Q1 2022 | share | Increase | +0.11% | 2.3K shares | 5.59M | $17.24 | 2.06M |
| Q4 2021 | share | Increase | +5.27% | 103.01K shares | -5.26M | $14.33 | 2.05M |
| Q3 2021 | share | Increase | +39.85% | 557.23K shares | 10.64M | $18 | 1.95M |
| Q2 2021 | share | Increase | +165.92% | 872.50K shares | 11.30M | $17.56 | 1.39M |
| Q1 2021 | share | Increase | 0.00% | 525.86K shares | 13.25M | $25.2 | 525.86K |